Houman Ashrafian

Houman Ashrafian

Founder at
Weatherden Ltd.
51 year
Health Technology
Commercial Services
Finance

Profile

Houman Ashrafian was the founder of Heart Metabolics Ltd. (2014), TRex Bio, Inc. (2018), HMBL Ltd. (2004), Sitryx Therapeutics Ltd. (2016) where the title of Director was held, and TRex Bio Ltd. (2018) where the title of Director was held.
Dr. Ashrafian is also the founder of Dualitas Ltd.,Catamaran Bio, Inc.,Weatherden Ltd.,Alchemab Therapeutics Ltd.,Mestag Therapeutics Ltd.,Enara Bio Ltd. Dr. Ashrafian is currently Director at Zarodex Therapeutics Ltd. since 2017, Director at Cellinta Ltd. since 2020, Director at Cybele Therapeutics Ltd. since 2019, Scientific Advisor at SV Health Investors LLP since 2016, and Managing Partner at SV Health Managers LLP since 2016.
Former positions include Chairman at Therini Bio, Inc., Director at Imbria Pharmaceuticals, Inc., Director at Prilenia Therapeutics BV, and Executive VP, Head-Research & Development at Sanofi from 2023 to 2026.
Education includes undergraduate and doctorate degrees from the University of Oxford, conferred in 1999 and 2009 respectively, and undergraduate and graduate degrees from the University of Cambridge.

Houman Ashrafian active positions

CompaniesPositionStart
Private Equity Investor 2015-12-31
Director/Board Member 2019-12-10
Director/Board Member 2020-03-09
Director/Board Member 2017-07-25
Portfolio Manager-Equities 2015-12-31
Founder -

Former positions of Houman Ashrafian

CompaniesPositionEnd
SANOFI Chief Tech/Sci/R&D Officer 2026-08-31
Founder 2017-06-02
Founder -
░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░ -
░░░░░ ░░░ ░░░░ ░░░░░░░ -
See the detail of Houman Ashrafian's experience

Training of Houman Ashrafian

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

100 +

1st degree connections

22

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies22

Finance

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Finance

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Houman Ashrafian